Camber Pharma Launches Generic Combivir®
Piscataway, NJ, September 20, 2014– Camber Pharmaceuticals announces that it has launched Lamivudine/Zidovudine, USP 150 mg/300mg tablets. The drug is the generic version of Combivir® tablets.
Lamivudine/Zidovudine is available only in 60 count bottle.
If you would like more information about this topic, please contact Megan Becker at 732.529.0436 or email at [email protected].
Recent articles
- NACDS TSE 2026 Event Recap
- Camber Specialty Marks First Day 1 Injectable Launch
- New to Camber’s Portfolio: Olmesartan medoxomil, Amlodipine and Hydrochlorothiazide Tablets
- Camber Pharmaceuticals Honored as Second Merit Finalist at 2026 DIANA Awards
- Camber Launches Nitazoxanide Tablets
- Cisatracurium Besylate Injection, USP Added to Camber’s Portfolio






